- Home
- News and Events
This section of the website contains the European Medicines Agency's news and press releases, information on meetings and events, public consultations and related information.
For a scrolling feed of all of the new and updated information published on the website, see the what's new page.
Latest news
-
2018-04-24 : EMA
The European Medicines Agency and the Netherlands agree on Seat Agreement
-
2018-04-23 : EMA
-
2018-04-20 : CVMP
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-19 April 2018
-
2018-04-20 : CVMP
Eye injuries in people and dogs when using Osurnia ear gel for dogs
-
2018-04-13 : PRAC
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 April 2018
-
2018-04-13 : PRAC
-
2018-04-12 : EMA
Increasing oversight of API manufacturing through international collaboration
-
2018-04-11 : EMA
Redistribution of UK’s portfolio of centrally authorised products
-
2018-04-09 : EMA
-
2018-03-28
Regulatory information – 1.7% increase of fees from 1 April 2018
-
2018-03-27 : EMA
-
2018-03-26 : EMA
EU recommendations for 2018/2019 seasonal flu vaccine composition
-
2018-03-23 : CHMP
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 March 2018
-
2018-03-23 : CMDh
New measures to avoid valproate exposure in pregnancy endorsed
-
2018-03-23 : CHMP
Updated measures for pregnancy prevention during retinoid use
-
2018-03-23 : CMDh
-
2018-03-23 : EMA
Colour change for insulin injection Fiasp to avoid mix ups with Tresiba
-
2018-03-22
Increased reporting of side effects of veterinary medicines helps to protect animal and human health
-
2018-03-19 : EMA
-
2018-03-16 : CVMP
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 March 2018
This month's events
-
2018-01-10 - 2018-01-11 : EMA
This hands-on training course covers the functionalities of the new EudraVigilance web application (EVWEB). It includes practical examples for creating, sending and accessing individual case safety reports in the new ISO/ICH E2B(R3) format. It covers reporting principles in accordance with the guideline on good pharmacovigilance practices (GVP) Module VI 'Management and reporting of adverse reactions to medicinal products' and explanations on how to comply with the EudraVigilance business rules and the EudraVigilance access policy.
-
2018-01-08 - 2018-01-11 : PRAC
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 January 2018
The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
Latest patient safety information
-
2018-04-20
Eye injuries in people and dogs when using Osurnia ear gel for dogs
-
2018-04-13
-
2018-03-23
New measures to avoid valproate exposure in pregnancy endorsed
-
2018-03-23
Updated measures for pregnancy prevention during retinoid use
-
2018-03-23
RSS feed
Twitter
YouTube
